Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
talazoparib
Pharma
ASCO Soundbites, vol. 3
With ASCO ending, it's time to round up our favorite quotes from the weekend. Read on to see the most colorful things pharma executives had to say.
Carly Helfand
Jun 4, 2019 10:45am
Half of doctors are still wary of PARPs: executive
Oct 24, 2018 11:06am
Can Pfizer's Talzenna really make a dent in the PARP field?
Oct 17, 2018 11:19am
PARP battle heats up as Pfizer nabs priority review in breast cancer
Jun 7, 2018 11:05am
Tesaro's up for sale, WSJ says. Who's likely to bid?
Jun 1, 2017 12:00pm
Tesaro's niraparib wins quick FDA nod
Mar 27, 2017 5:04pm
